Last updated on February 2018

Study of the Effects of Fabrazyme Treatment on Lactation and Infants


Brief description of study

The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months

Detailed Study Description

NOTE: Estimated Enrollment: 10 mothers and up to 10 infants

Clinical Study Identifier: NCT00230607

Contact Investigators or Research Sites near you

Start Over

Medical Information

Participation in this study is not limited to this facility; facilities not yet active may enroll upon identification of a patient
Cambridge, MA United States
  Connect »

Medical Information

Dallas, TX United States
  Connect »

Medical Information

Milwaukee, WI United States
  Connect »

Medical Information

Salford, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.